Cita APA

Prince, H. M., Gautam, A., & Kim, Y. H. (2018). Brentuximab vedotin: Targeting CD30 as standard in CTCL. Oncotarget.

Chicago Style Citation

Prince, H. Miles, Ashish Gautam, i Youn H. Kim. "Brentuximab Vedotin: Targeting CD30 As Standard in CTCL." Oncotarget 2018.

Cita MLA

Prince, H. Miles, Ashish Gautam, i Youn H. Kim. "Brentuximab Vedotin: Targeting CD30 As Standard in CTCL." Oncotarget 2018.

Atenció: Aquestes cites poden no estar 100% correctes.